Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelomonocytic, Chronic × Dasatinib × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Burkitt Lymphoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Philadelphia Chromosome 1 Pancreatic Neoplasms 1 Neuroblastoma 1 Neoplasm, Residual 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Acute 1 Brain Neoplasms 1 Blast Crisis 1

Interventions

Azacitidine 7 venetoclax 6 Specimen Handling 6 Biopsy 6 Injections 5 Stem Cell Transplantation 4 Decitabine 4 Cytarabine 4 fludarabine 3 Cyclophosphamide 3 olutasidenib 2 fludarabine phosphate 2 decitabine and cedazuridine drug combination 2 cedazuridine 2 X-Rays 2 Whole-Body Irradiation 2 Vorinostat 2 Mycophenolic Acid 2 Magnetic Resonance Spectroscopy 2 Lenalidomide 2 Hematopoietic Stem Cell Transplantation 2 Granulocyte Colony-Stimulating Factor 2 Filgrastim 2 Cyclosporins 2 Cyclosporine 2 Cladribine 2 Carboplatin 2 CPX-351 2 veliparib 1 treosulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡